• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

制备参数对壳聚糖-肝素纳米水凝胶典型特性的影响:粒径、载药效率和药物释放。

The impact of preparation parameters on typical attributes of chitosan-heparin nanohydrogels: particle size, loading efficiency, and drug release.

机构信息

Department of Pharmaceutics, School of Pharmacy, Shiraz University of Medical Sciences , Shiraz , Iran.

出版信息

Drug Dev Ind Pharm. 2013 Nov;39(11):1774-82. doi: 10.3109/03639045.2012.736518. Epub 2012 Nov 9.

DOI:10.3109/03639045.2012.736518
PMID:23136990
Abstract

Today, developing an optimized nanoparticle (NP) preparation procedure is of paramount importance in all nanoparticulate drug delivery researches, leading to expanding more operative and clinically validated nanomedicines. In this study, a one-at-a-time experimental approach was used for evaluating the effect of various preparation factors on size, loading, and drug release of hydrogel NPs prepared with ionotropic gelation between heparin and chitosan. The size, loading efficiency (LE) and drug release profile of the NPs were evaluated when the chitosan molecular weight, chitosan concentration, heparin addition time to chitosan solution, heparin concentration, pH value of chitosan solution, temperature, and mixing rate were changed separately while other factors were in optimum condition. The results displayed that size and LE are highly influenced by chitosan concentration, getting an optimum of 63 ± 0.57 and 75.19 ± 2.65, respectively, when chitosan concentration was 0.75 mg/ml. Besides, heparin addition time of 3 min leaded to 74.1 ± 0.79 % LE with no sensible effect on size and release profile. In addition, pH 5.5 showed a minimum size of 63 ± 1.87, maximum LE of 73.81 ± 3.13 and the slowest drug release with 63.71 ± 3.84 % during one week. Although LE was not affected by temperature, size and release reduced to 63 ± 0 and 74.21 ± 1.99% when temperature increased from 25°C to 55°C. Also, continuous increase of mixer rate from 500 to 3500 rpm resulted in constant enhancement of LE from 58.3 ± 3.6 to 74.4 ± 2.59 as well as remarkable decrease in size from 148 ± 4.88 to 63 ± 2.64.

摘要

今天,在所有纳米药物传递研究中,开发优化的纳米粒子(NP)制备程序至关重要,这将导致更多操作性和临床验证的纳米药物的扩展。在这项研究中,使用单因素实验方法评估了各种制备因素对肝素和壳聚糖之间离子凝胶化制备的水凝胶 NP 的粒径、载药量和药物释放的影响。当改变壳聚糖分子量、壳聚糖浓度、肝素加入壳聚糖溶液的时间、肝素浓度、壳聚糖溶液 pH 值、温度和混合速度等因素,而其他因素处于最佳条件时,评估了 NP 的粒径、载药量和药物释放曲线。结果表明,粒径和载药量高度受壳聚糖浓度的影响,当壳聚糖浓度为 0.75mg/ml 时,分别获得最佳的 63±0.57 和 75.19±2.65。此外,肝素加入壳聚糖溶液的时间为 3min 时,载药量为 74.1±0.79%,对粒径和释放曲线没有明显影响。此外,pH 值为 5.5 时,粒径最小为 63±1.87,载药量最大为 73.81±3.13,在一周内药物释放最慢,为 63.71±3.84%。虽然载药量不受温度影响,但当温度从 25°C 升高到 55°C 时,粒径和释放分别降至 63±0 和 74.21±1.99%。此外,当混合器转速从 500rpm 连续增加到 3500rpm 时,载药量从 58.3±3.6 持续增加到 74.4±2.59,粒径从 148±4.88 显著减小到 63±2.64。

相似文献

1
The impact of preparation parameters on typical attributes of chitosan-heparin nanohydrogels: particle size, loading efficiency, and drug release.制备参数对壳聚糖-肝素纳米水凝胶典型特性的影响:粒径、载药效率和药物释放。
Drug Dev Ind Pharm. 2013 Nov;39(11):1774-82. doi: 10.3109/03639045.2012.736518. Epub 2012 Nov 9.
2
Preparation, optimization, and in-vitro/in-vivo/ex-vivo characterization of chitosan-heparin nanoparticles: drug-induced gelation.壳聚糖-肝素纳米粒子的制备、优化及体内外特性研究:药物诱导凝胶化。
J Pharm Pharmacol. 2013 Aug;65(8):1118-33. doi: 10.1111/jphp.12076. Epub 2013 May 21.
3
Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.壳聚糖纳米结构用于提高低分子量肝素的口服递送:体外和体内评价。
Int J Pharm. 2012 Jan 17;422(1-2):179-84. doi: 10.1016/j.ijpharm.2011.10.048. Epub 2011 Nov 3.
4
Thermoreversible in situ gelling poloxamer-based systems with chitosan nanocomplexes for prolonged subcutaneous delivery of heparin: design and in vitro evaluation.基于壳聚糖纳米复合物的温敏原位凝胶泊洛沙姆系统用于肝素的皮下长效递送:设计与体外评价。
Eur J Pharm Sci. 2013 Sep 27;50(1):93-101. doi: 10.1016/j.ejps.2013.03.002. Epub 2013 Mar 21.
5
Intermolecular interactions between salmon calcitonin, hyaluronate, and chitosan and their impact on the process of formation and properties of peptide-loaded nanoparticles.鲑鱼降钙素、透明质酸和壳聚糖之间的分子间相互作用及其对载肽纳米颗粒形成过程和性质的影响。
Int J Pharm. 2014 Dec 30;477(1-2):102-12. doi: 10.1016/j.ijpharm.2014.10.023. Epub 2014 Oct 13.
6
Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation.通过聚电解质络合制备的肝素/壳聚糖纳米颗粒载体。
J Biomed Mater Res A. 2007 Dec 1;83(3):806-12. doi: 10.1002/jbm.a.31407.
7
Facile preparation of well-defined near-monodisperse chitosan/sodium alginate polyelectrolyte complex nanoparticles (CS/SAL NPs) via ionotropic gelification: a suitable technique for drug delivery systems.通过离子凝胶化制备形态均一的壳聚糖/海藻酸钠聚电解质复合纳米粒子(CS/SAL NPs):一种适合药物传递系统的技术。
Biotechnol J. 2013 Jul;8(7):847-54. doi: 10.1002/biot.201300093. Epub 2013 Jun 7.
8
Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.海藻酸包覆壳聚糖核壳纳米粒经口递送依诺肝素:体外与体内评价。
Int J Pharm. 2013 Nov 1;456(1):31-40. doi: 10.1016/j.ijpharm.2013.08.037. Epub 2013 Aug 29.
9
Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.壳聚糖-透明质酸纳米载肝素治疗哮喘。
Int J Pharm. 2009 Nov 3;381(2):122-9. doi: 10.1016/j.ijpharm.2009.04.009. Epub 2009 Apr 15.
10
Chitosan nanoparticle as protein delivery carrier--systematic examination of fabrication conditions for efficient loading and release.壳聚糖纳米颗粒作为蛋白质递送载体——高效负载与释放制备条件的系统研究
Colloids Surf B Biointerfaces. 2007 Sep 1;59(1):24-34. doi: 10.1016/j.colsurfb.2007.04.009. Epub 2007 Apr 24.

引用本文的文献

1
Emerging for non-invasive heparin delivery systems: recent advances, barriers, solutions, and applicability.新兴的非侵入性肝素递送系统:最新进展、障碍、解决方案及适用性
Saudi Pharm J. 2025 Jun 12;33(3):17. doi: 10.1007/s44446-025-00022-6.
2
Oleic Acid Coated Gelatin Nanoparticles Impregnated Gel for Sustained Delivery of Zaltoprofen: Formulation and Textural Characterization.载有油酸包覆明胶纳米颗粒的扎托洛芬缓释凝胶:制剂与质地特性研究
Adv Pharm Bull. 2015 Nov;5(4):537-48. doi: 10.15171/apb.2015.073. Epub 2015 Nov 30.